pimitespib   Click here for help

GtoPdb Ligand ID: 12284

Synonyms: compound 16e [PMID: 30525599] | Jeselhy® | TAS-116 | TAS116
Compound class: Synthetic organic
Comment: Pimitespib (TAS-116) is an orally bioavailable heat shock protein 90 α/β (HSP90α/β) inhibitor [6], that promotes proteasomal degradation of oncogenic HSP90 client proteins, and induces apoptosis of cells that overexpress (HSP90α/β). Reported to bind at the N-terminal ATP binding site of the target proteins [6]. Pimitespib was developed for potential antineoplastic activity [1,3-5].
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 6
Hydrogen bond donors 1
Rotatable bonds 6
Topological polar surface area 108.4
Molecular weight 454.22
XLogP 3.87
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES CCc1cc(ccc1n1nc(c2c1nccc2n1cnc(c1)c1cnn(c1)C)C(C)C)C(=O)N
Isomeric SMILES CCc1c(ccc(c1)C(=O)N)n1c2nccc(c2c(n1)C(C)C)n1cc(nc1)c1cn(nc1)C
InChI InChI=1S/C25H26N8O/c1-5-16-10-17(24(26)34)6-7-20(16)33-25-22(23(30-33)15(2)3)21(8-9-27-25)32-13-19(28-14-32)18-11-29-31(4)12-18/h6-15H,5H2,1-4H3,(H2,26,34)
InChI Key NVVPMZUGELHVMH-UHFFFAOYSA-N
No information available.
Summary of Clinical Use Click here for help
Pimitespib was first approved for clinical use in Japan in July 2022 [2], as a treatment for gastrointestinal stromal tumour (GIST) that has progressed after chemotherapy.